STOCK TITAN

Pharvaris N.V. (PHVS) CEO sells 2,292 shares in Rule 10b5-1 stock plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

On July 13, 2026, Pharvaris N.V. Chief Executive Officer Berndt Modig executed an open-market sale of 2,292 shares of common stock at a weighted average price of $34.9714, pursuant to a scheduled Rule 10b5-1 trading plan. Following this sale, he holds 132,917 shares directly and 950,000 shares indirectly through Schoodic Management BV.

Positive

  • None.

Negative

  • None.
Insider Modig Berndt
Role Chief Executive Officer
Sold 2,292 shs ($80K)
Type Security Shares Price Value
Sale Common Stock 2,292 $34.9714 $80K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 132,917 shares (Direct); Common Stock — 950,000 shares (Indirect, By Schoodic Management BV)
Footnotes (1)
  1. This is a scheduled sale from 10b5-1 trading plan. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $34.68 to $35.11. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Schoodic Management BV, an entity controlled by Mr. Modig.
Shares Sold 2,292 shares Open-market sale by CEO Berndt Modig on July 13, 2026
Weighted Average Sale Price $34.9714 per share Average price for multiple sale transactions on July 13, 2026
Direct Holdings After Transaction 132,917 shares Common stock held directly by Berndt Modig following the sale
Indirect Holdings via Schoodic Management BV 950,000 shares Common stock held indirectly through Schoodic Management BV controlled by Modig
Sale Price Range $34.68–$35.11 per share Range of prices for individual trades included in the reported sale
Rule 10b5-1 trading plan regulatory
"scheduled sale from <b>10b5-1 trading plan</b>"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The reported price represents a <b>weighted average sale price</b>"
restricted stock units financial
"shares of common stock acquired upon vesting of <b>restricted stock units</b>"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
indirect ownership financial
"total shares following transaction reported as <b>indirect</b> ownership"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Pharvaris (PHVS) CEO Berndt Modig report?

Pharvaris CEO Berndt Modig reported selling 2,292 shares of common stock on July 13, 2026. The sale was an open-market transaction executed under a scheduled Rule 10b5-1 trading plan, with a weighted average price of $34.9714 per share.

At what price did the Pharvaris (PHVS) CEO sell his shares?

Berndt Modig’s reported sale used a weighted average price of $34.9714 per share. According to the disclosure, individual sale prices for the transactions on July 13, 2026 ranged between $34.68 and $35.11, all executed under a Rule 10b5-1 trading plan.

How many Pharvaris (PHVS) shares does CEO Berndt Modig hold after this Form 4?

After the reported sale, Berndt Modig holds 132,917 Pharvaris common shares directly. He also has an indirect holding of 950,000 shares through Schoodic Management BV, an entity he controls, giving him substantial ongoing exposure to Pharvaris equity.

Was the Pharvaris (PHVS) CEO’s share sale made under a Rule 10b5-1 trading plan?

Yes. The reported transaction is described as a scheduled sale under a Rule 10b5-1 trading plan. Such plans pre-arrange trade timing and size, which can reduce the significance of trade timing as an indicator of the insider’s current view of the company.

What is Schoodic Management BV’s role in the Pharvaris (PHVS) CEO’s holdings?

Schoodic Management BV holds 950,000 Pharvaris shares indirectly for CEO Berndt Modig. The filing states that Schoodic Management BV is an entity controlled by Mr. Modig, meaning these indirectly owned shares are associated with his economic interest in Pharvaris.

Do the reported Pharvaris (PHVS) sales include shares from restricted stock units (RSUs)?

Yes. The disclosure notes that the shares sold include common stock acquired upon vesting of restricted stock units on various dates. All such shares were sold in multiple transactions at prices between $34.68 and $35.11 under the same Rule 10b5-1 plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Modig Berndt

(Last)(First)(Middle)
1 CRANBERRY HILL SUITE 400

(Street)
LEXINGTON MASSACHUSETTS 02421

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/13/2026S(1)2,292D$34.9714(2)132,917D
Common Stock950,000IBy Schoodic Management BV(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This is a scheduled sale from 10b5-1 trading plan.
2. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $34.68 to $35.11. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3. Schoodic Management BV, an entity controlled by Mr. Modig.
/s/ Marnus Nel, Attorney-in-Fact for Berndt Modig07/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)